Related by context. All words. (Click for frequent words.) 70 sd rxRNA 66 rxRNA 66 DiLA2 63 lipid nanoparticles 63 Chemetics R 62 Anticalins R 62 sd rxRNA ™ 62 predictive biomarker 61 isoform selective 61 stable nucleic acid 61 DsiRNA 60 Fleximer 60 p# inhibitor 60 Anticalins ® 60 HepDirect R 60 Locked Nucleic Acid LNA 60 Novolimus 60 metabolomic profiling 59 MDRNA proprietary 59 humanized monoclonal antibodies 59 sirtuin modulators 59 liposomal formulation 59 sd rxRNA compounds 59 encapsulates siRNAs 59 PORxin TM 59 ENMD # 59 OMP #M# 59 biomarker assays 59 IAP inhibitor 59 systemic RNAi 59 Micromet BiTE 59 UsiRNAs 59 histone deacetylase HDAC 59 massively parallel sequencing 59 miRNA biomarkers 59 therapeutic radiopharmaceuticals 58 vivo electroporation 58 Alexza Staccato 58 Fibroblast Growth Factor Receptor 58 PI3K/Akt pathway inhibitor 58 DiLA2 Platform 58 novel VDA molecule 58 acetonide FA 58 tkRNAi 58 eTag assays 58 JAK2 inhibitor 58 molecular biomarkers 58 Litx 58 Alfacell proprietary ribonuclease 58 preclinical efficacy 58 AKT inhibitor 58 proprietary PEGylation 58 Enhanze Technology 58 proprietary LNA 58 therapeutic monoclonal antibody 58 telomerase inhibitor 58 optical biosensors 58 Nanobody 58 HGS ETR1 mapatumumab 58 selective inhibition 58 HGS# 58 Fleximer R 58 adenoviral vectors 58 Anticalin 58 SMARTICLES ® 58 radiation dosimetry 58 RNAi therapeutic targeting 58 Trofex 58 PDE4 inhibitor 58 LNPs 58 CYT# potent vascular disrupting 58 DuraSite 58 investigational humanized monoclonal antibody 58 proprietary transdermal 58 novel peptide 58 nitric oxide donating 58 THR beta agonist 58 Azedra 57 FGFR 57 XmAb 57 FOLOTYN ® 57 metabolite identification 57 selective kinase inhibitor 57 pan HDAC inhibitor 57 IAP inhibitors 57 NuMimetic TM 57 LNP formulations 57 siRNA therapeutics 57 Activity Assay 57 AAG geldanamycin analog 57 siRNA delivery 57 generation nucleoside analog 57 novel immunotherapeutic 57 Nanobodies 57 AAV vectors 57 DepoVax TM 57 Cyclosert 57 Nanobodies ® 57 EyeGate ® II 57 HTRF 57 DOS# 57 neuroprotective properties 57 oral transdermal 57 kidney urologic 57 JAK inhibitors 57 DNA methylation biomarkers 57 LHRH antagonists 57 ocular formulation 57 MDx tests 57 NovaBay Aganocide compounds 57 anti amnesic 57 sulfonylhydrazine class 57 metabolite profiling 57 liposomal delivery 57 vinca alkaloid 57 Fc fusion protein 57 vivo fluorescence imaging 57 MEK inhibitors 57 M2 subunit 57 small molecule activators 57 SNALP technology 57 product platforms AZX# 57 Squalamine 57 lipid particles 57 XmAb ® 57 oligonucleotide therapeutics 56 Inovio DNA 56 NTDDS 56 lipid nanoparticle 56 ATL# [002] 56 biologic therapeutics 56 PKC# 56 Locked Nucleic Acid 56 CCX# 56 Nanobody ® 56 anticancer therapeutics 56 tranilast 56 Epigenomics proprietary 56 ophthalmic therapeutics 56 TG# [003] 56 Cobalamin TM mediated 56 targeted radiotherapeutic 56 CobaCyte 56 novel RNAi therapeutics 56 RONDEL ™ 56 DiLA 2 56 multiplex assay 56 Hemopurifier ® 56 RNAi compounds 56 genomic biomarkers 56 BiTE 56 predictive biomarkers 56 Soliris eculizumab 56 proteomics bioinformatics 56 INS# [001] 56 oral salmon calcitonin 56 antisense oligonucleotides 56 Receptors GPCRs 56 immunotherapeutics 56 Cyclosert TM 56 MetaBase TM represents 56 Spiegelmers ® 56 siRNA therapeutic 56 nucleotide analog 56 HeliScope Sequencer 56 vascular disrupting agents 56 siRNAs targeting 56 NeoLipid R 56 cleavable linker 56 introduced NEUGENE 56 targeting CD# 56 beta Estradiol 56 multi kinase inhibitor 56 small molecule agonists 56 Tekmira SNALP technology 56 Spiegelmer 56 platinum chemotherapeutic 56 evaluating tivozanib 56 Anticalin R 56 BrachySil TM 56 DPX Survivac 56 miRview mets 56 anti CD# antibodies 56 RNA antagonists 56 oral prodrug 56 vitro ADME 55 Factor VIIa 55 xenograft models 55 Protein Kinase C 55 radiation sensitizer 55 Lixivaptan 55 ArQule Kinase Inhibitor Platform 55 NEUGENE R 55 NADiA 55 oxidative stress inducer 55 Sym# 55 aerosolized KL4 surfactant 55 mda 7 55 Sphingomab 55 nonclinical studies 55 quantitative gene expression 55 tkRNAi technology 55 Vaxfectin R 55 Panzem R NCD 55 SMaRT ™ 55 ddRNAi 55 Tarvacin TM 55 ALN PCS 55 XL# inhibits 55 preclinically 55 DURECT proprietary 55 Preclinical studies suggest 55 RONDEL TM 55 G Protein Coupled 55 microdroplet based 55 SiMoA 55 tSMS 55 miRNA therapeutics 55 siRNA sequences 55 HuMax 55 rxRNA compounds 55 AMPK activators 55 Symadex 55 ALN HTT 55 punctal plug drug 55 humanized antibody 55 Curaxin CBLC# 55 FOLFOX6 chemotherapy regimen 55 intranasal delivery 55 Nektar pulmonary 55 kinase profiling 55 taxane derivative 55 VBLOC TM 55 molecular chaperone regulation 55 HSP# inhibitor 55 Tekmira lipid nanoparticle 55 OXi# 55 metaglidasen 55 ImmunoBody ® 55 PDE4 inhibitors 55 biomarker validation 55 Aganocide ® 55 Mutation Analysis 55 MSn 55 LentiVector technology 55 Novosom 55 microRNA profiling 55 JAK2 inhibitors 55 2 inhibitor CYT# 55 CellPort Technologies 55 bioconjugation 55 miRview ™ squamous 55 combinatorial libraries 55 prodrugs 55 catheter occlusion CO 55 selectively induce apoptosis 55 tubulin inhibitor 55 DETERx ™ 55 CB2 selective 55 hematological tumors 55 Curaxin 55 Xanafide 55 Angiocept 55 predictive toxicology 55 MetMAb 55 novel histone deacetylase 55 CBLC# 55 potently inhibited 55 proprietary electroporation 55 Western Blotting 55 SNALP 54 Selective Electrochemical Tumor Ablation 54 inhaled iloprost 54 RONDEL 54 HGS ETR2 54 CCR9 antagonist 54 metabonomics 54 biochemical profiling 54 oral renin inhibitor 54 DepoVax 54 S1P antibody 54 multiplex PCR 54 targeting PCSK9 54 NP2 Enkephalin 54 BioSilicon TM 54 multiplexed assays 54 Stapled Peptide 54 Epothilones 54 antiangiogenic agent 54 Isis antisense 54 OnDose TM 54 MGN# 54 AvalonRx R 54 adrenergic regulation 54 oncolytic 54 ANG# 54 TomoDirect ™ 54 demonstrated antitumor activity 54 cancer immunotherapies 54 SGLT Inhibitors 54 BRAF kinase 54 EndoTAG TM 54 selective kinase inhibitors 54 CellOptics platform 54 therapeutic peptide 54 HepDirect 54 siRNA compounds 54 ALN TTR# 54 pharmacogenetic testing 54 potency selectivity 54 protein biomarker 54 patented Bioral 54 Bioral Amphotericin B. 54 tyrosine kinase inhibitor 54 buccal delivery 54 molecular assays 54 Inc. AMEX YMI 54 CG# [003] 54 IMA# 54 Exelixis compounds 54 diagnostic prognostic 54 proteomic analyzes 54 multiparametric 54 vivo preclinical 54 opto acoustic 54 HCV protease inhibitors 54 Adnectin 54 epothilones 54 immunoregulation 54 prostone 54 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 54 humanized anti 54 proteasome inhibitors 54 transdermal gel 54 small molecule PEGylation 54 Synavive ™ 54 potent suppressor 54 AEG# 54 delta isoform 54 AtuRNAi 54 fosbretabulin 54 Bioral 54 CINtec ® PLUS 54 molecularly targeted 54 ZFP Therapeutics 54 rxRNA TM compounds 54 vivo efficacy 54 antagomirs 54 Fibrin MB 54 transfection efficiency 54 synDNA 54 myelofibrosis polycythemia vera 54 IMiDs R 54 multiplex assays 54 immune modulatory 54 near infrared spectroscopic 54 novel therapeutic antibodies 54 Corus CAD 53 AtuPLEX 53 KRAS mutation status 53 miRagen 53 qualitative serum 53 Bavarian Nordic patented 53 commercializing anti infective 53 pharmacological chaperone 53 DUROS 53 Guanilib 53 Armed Antibodies 53 acne impetigo 53 Janus kinase 53 genomic profiling 53 mediate RNAi 53 liposomal 53 Abbott ARCHITECT 53 novel immunomodulatory 53 developing topically administered 53 MVA BN R 53 novel antiviral therapeutics 53 protein quantitation 53 short interfering RNA 53 purine analog 53 ChronVac C R 53 LightLab OCT 53 PNP inhibitor 53 therapeutic monoclonal antibodies 53 tiapamil 53 lipid particles SNALP 53 PEGylated interferon 53 proprietary phage display 53 vascular disrupting agent 53 JAK inhibitor 53 silico prediction 53 protein kinase inhibitors 53 OvaRex R 53 lipidoid 53 intracellular signaling pathways 53 MTP inhibitor 53 OXIGON TM 53 Biomerk Tumorgrafts 53 KL4 surfactant 53 CINTREDEKIN BESUDOTOX 53 Nasdaq CGEN 53 Personalized Immunotherapy 53 carbohydrate polymers 53 biophotonic 53 JAK1 53 inhibits VEGF 53 PARP inhibitors 53 Inovio electroporation 53 HuLuc# 53 Ampakine compounds 53 novel antibody therapeutics 53 atacicept 53 microRNA therapeutics 53 favorable pharmacokinetic profile 53 SPC# [001] 53 siRNA conjugates 53 viral inactivation 53 proteasome inhibitor 53 anticancer therapies 53 Endotis 53 Kamada AAT 53 RNA interference RNAi therapeutics 53 Solazed TM 53 exon skipping 53 antitumoral 53 OncoVEX 53 Bioral R 53 selectively inhibiting 53 Affibody 53 EfficiencySMART 53 preclinical compounds 53 antisense drug 53 oral antiviral 53 toxicogenomic 53 Pfenex Expression Technology 53 PharmFilm 53 PEG SN# 53 DiLA2 liposomes 53 Curaxins 53 NexACT 53 Hsp# inhibition 53 VEGF receptor 53 resolvins 53 liposome formulations 53 visit www.genenews.com 53 HDAC EGFR 53 anti angiogenic drugs 53 MET amplification 53 multitargeted 53 Anavex #-# 53 endothelin receptor 53 ZFP technology 53 MassARRAY platform 53 Novasome R 53 non nucleoside HCV 53 P2V TM 53 Tekmira SNALP stable 53 immuno inflammatory 53 delipidation 52 CompuFlo 52 investigational therapies 52 aldehyde dehydrogenase ALDH2 deficiency 52 biomolecular interactions 52 selective orally bioavailable 52 nitric oxide donating prostaglandin 52 Dyax phage display 52 potent antitumor activity 52 renin inhibitors 52 NYSE Amex PBTH 52 PI3K inhibitors 52 Hedgehog signaling pathway 52 ImmuKnow R 52 resolvin 52 ophthalmology oncology 52 autologous cellular therapy 52 radiolabelled 52 Tempo inhaler 52 xTAG RVP 52 Inovio proprietary electroporation 52 generation antisense 52 Enkephalin 52 theranostic 52 dAbs 52 antisense drugs 52 Archexin 52 microRNA biomarkers 52 TÎ ² 4 52 TLR9 agonists 52 RenaZorb TM 52 motexafin gadolinium Injection 52 molecularly targeted therapies 52 Transdel TM 52 MedPulser 52 HIFU therapy 52 novel peptides 52 transcutaneous immunization TCI 52 lentiviral vector 52 systemic siRNA 52 protein microarrays 52 BCR ABL inhibitors 52 IMiDs ® 52 BiTE antibody 52 druggable targets 52 Captisol ® 52 HTS assay 52 deforolimus 52 Anticalins 52 DiLA2 platform 52 kinase inhibitors 52 siRNA molecules 52 DEEP AF 52 Mammostrat 52 NNRs 52 Chemophase 52 Tarmogen 52 lymphatic mapping 52 Azedra ™ 52 COX Inhibiting Nitric Oxide 52 anti infective treatments 52 Hedgehog inhibitor 52 immune modulation 52 angiogenesis inhibitor 52 oncology therapeutics 52 GAP #B# 52 polymerase inhibitors 52 aptamer therapeutics 52 proprietary Dicer Substrate Technology 52 DAVANAT R 52 amaZon 52 A3 adenosine receptor 52 Factor 5A 52 bioresorbable stent 52 AAV vector 52 Affilin ® 52 Romidepsin 52 Phase #b/#a trial 52 affinity purification 52 Vaxfectin R adjuvant 52 Onalta 52 SEQureDx Technology 52 NADiA ProsVue 52 BACcel ™ system 52 HyACT 52 orally disintegrating 52 BHT DNA 52 Geron telomerase 52 Ii protein 52 Etubics 52 CA9 SCAN 52 VitiGam 52 TNF alpha selectively neutralizing 52 monoclonal antibody therapeutics 52 RNA antagonist 52 ABL1 52 ChemoFx ® 52 enhance ApoA 52 PHX# 52 vivo validation 52 PEGylation technology 52 AKIP 52 R#/MEM # 52 immatics 52 ATD gel 52 PharmFilm ® 52 catalytic antioxidant compounds 52 Avantra 52 immunofluorescence staining 52 ImmuneY2 52 ALN TTR 52 therapeutics diagnostics 52 TLR antagonists 52 huC# DM4 52 vitro dissolution 52 histone deacetylase inhibitors 51 HCV protease 51 vinca alkaloids 51 Psynova 51 subsidiary Cira Biosciences 51 recombinant vaccines 51 punctal plug delivery 51 antibody humanization 51 protein biochip 51 Omacetaxine 51 Nasdaq IDRA today 51 AKIP ™ 51 HCV protease inhibitor 51 oral transmucosal 51 3 kinase PI3K 51 NP2 51 OX1 51 Technology LVT 51 proprietary NexACT ® 51 BEMA TM 51 metalloenzymes 51 entinostat 51 CardioPET 51 Nasulin ™ 51 Novo TTF 51 ATD TM gel 51 PolyActive 51 next generation URAT1 51 Onconase 51 ResponseDX 51 optical coherence tomography OCT 51 Cardio3KG 51 AEMD 51 DCVax R 51 chemically modified siRNA 51 LungExpress Dx TM 51 TRAIL receptor antibodies 51 protein electrophoresis 51 vaccines oncolytic virus 51 monoclonal antibody MAb 51 Caliper LabChip 51 Panzem R 51 PET myocardial perfusion 51 orally bioavailable 51 ProSanos 51 P#X# antagonist 51 NuroPro R 51 Aptamers 51 AVI NEUGENE 51 ApoB SNALP 51 antimetastatic 51 EECP ® therapy 51 sodium glucose cotransporter 51 PI3K delta 51 Aganocide 51 AFFITOME R 51 Interferon beta 51 Imprime PGG ® 51 PD2i Analyzer 51 small molecule defensin 51 TPI ASM8 51 telomerase inhibitors 51 Theranostics 51 DXL# 51 GeneICE 51 Nerve Targeting Drug 51 skip exon 51 SARMs 51 ProteinChip 51 biomarker identification 51 LentiVector 51 includes TOLAMBA TM 51 NEUGENE 51 pharmacophore 51 Panzem 51 Affymetrix GeneChip 51 AN# novel 51 statistically significant efficacy 51 Vindicator LWS 51 TRIST study 51 oncolytics 51 Aeroquin 51 antiangiogenesis therapies 51 validating biomarkers 51 ProSavin 51 systemic RNA interference 51 Solorel TM 51 ThermaVolt 51 tumor xenografts 51 Homspera TM 51 biologic therapies 51 Pepducin 51 PEGylated 51 NASDAQ INGN 51 GPR# agonists 51 generation sequencing NGS 51 pharmacokinetic profiles 51 Oncotype DX colon cancer 51 Alnylam RNAi 51 Hydrogen Generating System 51 exome capture 51 UCOE 51 nucleic acid lipid 51 automated immunoassay 51 anticancer agents 51 putative biomarkers 51 Phase 1a clinical 51 Time Resolved Fluorescence 51 NEUGENE antisense 51 Nasdaq ALNY 51 XmAb# 51 UltiMAb 51 TTR amyloidosis 51 Ceflatonin 51 cytometer 51 ATL# [001] 51 Oracea TM 51 humanized antibodies 51 Sangamo ZFP technology 51 Infinium assay 51 differentially expressed proteins 51 Surfactant Replacement Therapy 51 #ME# 51 RenalGuard System TM 51 PLK1 SNALP 51 cerebral oximetry 51 immunoblot 51 endothelial progenitor cell 51 preclinical pharmacology 51 immunological diseases 51 XD3 51 covalent drugs 51 GRN# 50 VEGF Trap 50 biomarker assay 50 IgG1 antibody 50 Reverse Cholesterol Transport 50 Transdel TM platform 50 Zysolin TM 50 MEK inhibitor 50 LSI #P 50 therapeutic modality 50 chemotherapeutic drugs 50 Electronic Brachytherapy 50 radiolabeling 50 IL-#/# 50 adipiplon 50 HIV integrase inhibitors 50 Viprovex TM 50 Galenea 50 Dicer Substrate Technology 50 iSONEP 50 whole genome genotyping 50 favorable pharmacokinetic 50 trodusquemine 50 intranasal insulin 50 human antibody therapeutics 50 PN# [001] 50 anti JCV antibody 50 Pitavastatin 50 small molecule inhibitors 50 Luminex Corporation Nasdaq LMNX 50 GLPG# 50 PLAC test 50 Affibody ® molecules 50 multicenter Phase II 50 TRACON Pharmaceuticals 50 OTCBB NRGX 50 HQK 50 DiaryPRO 50 HuCAL 50 ClearPath TM 50 methylation profiling 50 serum biomarker 50 GeneSightRx 50 Hydrogel Nanoparticle Aggregate 50 LabChip GX 50 RainStorm 50 Adenosine Therapeutics 50 using ImmunoGen TAP 50 ZEVALIN ® 50 RNA sequencing 50 bioactive lipids 50 Nektar PEGylation technology 50 DNA methylation markers 50 anticoagulant reversing agent 50 transcranial 50 molecular chaperone 50 oncolytic viruses 50 HPV genotyping 50 respiratory gating 50 immunomodulatory 50 xMAP technology 50 AP# [003] 50 Florbetapir 50 AQUA ® 50 ColoMarker 50 Inc. Nasdaq ALNY 50 REOLYSIN ® 50 menstrual stem cell 50 gene silencing sequences 50 Unit Dose Budesonide 50 immunotherapeutic approaches 50 Tarvacin Anti Cancer 50 Nexavar ® 50 Dynabeads 50 immunotherapeutic vaccine 50 sirtuin therapeutics 50 NeutroSpec TM 50 synDNA TM 50 Genedata Expressionist 50 allosteric modulation 50 ASONEP TM 50 SELDI 50 antisense oligonucleotide 50 HDL Mimetic Peptide 50 chemogenomics 50 BioFocus DPI Galapagos 50 Xcellerated T Cells 50 ADVIA Centaur 50 INT# [002] 50 histone deacetylase HDAC inhibitor 50 Referenced EEG ® 50 antisense 50 genomic discoveries 50 WaveScan 50 single molecule sequencing 50 OHR/AVR# 50 gene expression assays 50 protein biomarker discovery 50 epigenetic therapies 50 gallium containing 50 histone deacetylase HDAC inhibitors 50 theranostics 50 Nasdaq PARD biopharmaceutical 50 engineered proteases 50 BrachySil ™ 50 PharmFilm R 50 transrenal DNA 50 mitotic kinesins 50 ALN VSP 50 iPSC technology 50 chemotherapeutics 50 myeloproliferative disorders 50 PCR Polymerase Chain Reaction 50 tezampanel 50 genetic biomarkers 50 selective androgen receptor modulators 50 TTR gene 50 Eligen ® Technology 50 AMPAKINE 50 PharmaPros 50 novel mTOR inhibitor 50 SpectraMax R 50 OGeS 50 RNAi Therapeutics 50 CellCiphr 50 Ampligen ® 50 CR# vcMMAE 50 SERCA2a 50 prognostic biomarker 50 Nasdaq OMER 50 Y2 receptor 50 enzyme kinetics 50 Cytori Celution System 50 DNAi 50 CryoMaze 50 elotuzumab 50 quantitative proteomics 50 Mipomersen 50 LTQ Orbitrap 50 RT qPCR 50 oral taxane 50 #F AV 49 Nasdaq LXRX biopharmaceutical 49 CAMBRIDGE Mass. Alnylam Pharmaceuticals 49 ghrelin antagonist 49 oral anticancer 49 anti atherothrombotic 49 Gene Ontology terms 49 Sudhir Agrawal D.Phil 49 throughput mass spectrometry 49 Vascular Endothelial Growth 49 Hsp# inhibitor 49 intestinal mucosal 49 MorphoSys antibody 49 world safest multivalent 49 VITAL Trial 49 quantitative PCR qPCR 49 Chrysalin 49 TLR Therapeutics 49 antibody therapies 49 photodisinfection 49 cyclophilin inhibitors 49 positioned Aastrom 49 topical hemostat 49 EthosFR + 49 ANAVEX #-# [001] 49 investigational monoclonal antibody 49 JAK3 49 BrachySil 49 photon counting 49 hESC derived 49 Nanobodies R 49 florbetaben 49 Pervasis 49 pharmaceutically relevant 49 induced tumor regression 49 pharmacokinetic pharmacodynamic 49 hematological cancers 49 amide hydrolase 49 triple quadrupole mass spectrometer 49 wilate ® 49 Tumor Necrosis Factor 49 proprietary Biochronomer 49 Vascugel 49 XTEN 49 NASDAQ FLML 49 LabChip XT 49 Synageva 49 NexACT ® 49 Aestus 49 COLD PCR 49 mocetinostat MGCD# 49 Scancell 49 Aethlon Hemopurifier 49 histone methyltransferases HMTs 49 topically delivered 49 engineered RAP peptides 49 Phylomer ® 49 SpyGlass System 49 VeraTag 49 Cooled ThermoTherapy 49 biobetter 49 iontophoretic 49 APTIMA 49 vaccine ChronVac C 49 MALDI imaging 49 anticancer agent 49 QTinno 49 Delivery System NTDDS 49 Ventavis ® 49 synthetic retinoid 49 using Inovio MedPulser 49 LTQ Orbitrap XL 49 topical dermatology 49 CORT # 49 Avantra Biosciences 49 multimodality imaging 49 Abiraterone acetate 49 CVac 49 bioseparation 49 predictive diagnostics 49 proprietary NexACT R 49 CEQ# 49 EGEN 49 novel anti infective 49 Cylene 49 vivo molecular imaging 49 delivered RNAi therapeutic 49 therapeutic mAbs 49 punctal plugs 49 DCE MRI 49 SpectraMax 49 novel immunotherapies 49 pharmacokinetic PK 49 QTinno TM 49 CRLX# 49 molecular diagnostic assay 49 anticancer compounds 49 Ceflatonin R 49 BioMAP Systems 49 small molecule 49 ADME Tox 49 Guava PCA systems 49 Hsp# inhibitors 49 identify protein biomarkers 49 KineMed 49 diagnostic biomarkers 49 ERYtech Pharma 49 Celator 49 CTLA4 Ig 49 antifolate 49 Mass spectrometry 49 Vascugel ® 49 molecular diagnostic assays 49 epothilone 49 NNR Therapeutics 49 INCB# [001] 49 Ibis T# Biosensor System 49 Omacetaxine mepesuccinate 49 APR Labtec 49 NurOwn 49 Nasdaq HALO biopharmaceutical 49 MALDI TOF 49 retinal disorders 49 oral NKTR 49 Warfarin Sensitivity Test 49 oncolytic vaccine 49 MaxCyte STX 49 renin inhibition promising 49 AERx R 49 biotherapeutics 49 oral PTH 49 nebulized budesonide 49 HemeScan 49 intravascular hemolysis 49 pralatrexate 49 nCounter 49 obatoclax 49 proprietary BEMA 49 Combivir Kivexa 49 radezolid 49 antisense therapeutics 49 AngioChem 48 antibody fragment therapeutics 48 inhaled formulation 48 Inc. OTCBB LPTN 48 TKB# 48 genomics proteomics 48 anticancer therapy 48 LungAlert TM 48 Nasdaq IDRA 48 immuno inflammatory diseases 48 HCV antiviral